Pacira BioSciences, Inc. (PCRX) — Capital Reinvestment Ratio
Pacira BioSciences, Inc. (PCRX) has a Capital Reinvestment Ratio of 0.11x as of March 2026, meaning it reinvests 0% of its operating cash flow ($25.68 Million) in capital expenditures ($2.72 Million). See Pacira BioSciences, Inc. (PCRX) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pacira BioSciences, Inc. Capital Reinvestment Ratio (2014–2025)
This chart tracks Pacira BioSciences, Inc.'s Capital Reinvestment Ratio across 12 annual periods. Check cash flow reinvestment rate of Pacira BioSciences, Inc. to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Pacira BioSciences, Inc. (2014–2025)
Year-by-year Capital Reinvestment Ratio for Pacira BioSciences, Inc. from 2014 to 2025. For live market cap and broader valuation context, see Pacira BioSciences, Inc. stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | $151.99 Million | $15.33 Million | ▲ +79.6% |
| 2024 | 0.06x | $189.39 Million | $10.64 Million | ▼ -42.7% |
| 2023 | 0.10x | $154.65 Million | $15.16 Million | ▼ -52.6% |
| 2022 | 0.21x | $145.27 Million | $30.08 Million | ▼ -43.3% |
| 2021 | 0.36x | $125.72 Million | $45.87 Million | ▼ -25.7% |
| 2020 | 0.49x | $77.03 Million | $37.80 Million | ▲ +240.6% |
| 2019 | 0.14x | $70.52 Million | $10.16 Million | ▼ -51.5% |
| 2018 | 0.30x | $48.87 Million | $14.51 Million | ▼ -72.6% |
| 2017 | 1.08x | $17.79 Million | $19.27 Million | ▲ +46.7% |
| 2016 | 0.74x | $33.45 Million | $24.71 Million | ▼ -48.1% |
| 2015 | 1.42x | $29.00 Million | $41.27 Million | ▲ +65.6% |
| 2014 | 0.86x | $25.47 Million | $21.89 Million | — |